|
|
Sorafenib Plus Dacarbazine Shows Promise in Advanced Melanoma
|
| Link ID |
6128 |
| Title |
Sorafenib Plus Dacarbazine Shows Promise in Advanced Melanoma |
| Url |
http://www.medscape.com/viewarticle/574987?src=rss |
| Description |
In a phase II study of chemotherapy-naive patients with stage III (unresectable) or stage IV melanoma, the addition of the Raf kinase inhibitor sorafenib to dacarbazine yielded an "encouraging" improvement in progression-free survival, the primary endpoint, and was well tolerated, researchers report. Reuters Health Information |
| Category |
Articles > Dermatology |
| Keywords |
|
| Date |
May 29, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Dermatology |
| 1. |
Melanoma Survival Worse With Scalp or Neck Involvement
|
|
|
Melanomas of the neck or scalp are associated with worse survival than those affecting other sites, including those involving the nearby face and ears, according to a report in the Archives of Dermatology for April. Reuters Health Information
|
| 5. |
Aesthetic Medicine
|
|
|
In this issue: rethinking char removal during ablative laser resurfacing; BTX-A and emotions; and more.
Medscape Dermatology
|
|
|
